Anna Ambrosini

Anna Ambrosini

Auto-generated profile, based on publicly available information

Anna Ambrosini

Headache Clinic, IRCCS INM Neuromed, Pozzilli, Italy

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2014 in Nature Reviews Neurology
Verified
Journal Article
Closed access
PDF file
Marina De TommasoMarina De Tommaso
Marina De Tommaso
AAAnna Ambrosini
Anna Ambrosini
Filippo BrighinaFilippo Brighina
Filippo Brighina
GCGianluca Coppola
Gianluca Coppola
APArmando Perrotta
Armando Perrotta
JSJean Schoenen
Jean Schoenen

1 November 2005 in Pain
Verified
Journal Article
Closed access
AAAnna Ambrosini
Anna Ambrosini
MVMichel Vandenheede
Michel Vandenheede
PRPaolo Rossi
Paolo Rossi
FAFulvio Aloj
Fulvio Aloj
ESEnzo Sauli
Enzo Sauli
JSJean Schoenen
Jean Schoenen
Oral steroids can interrupt bouts of cluster headache (CH) attacks, but recurrence is frequent and may lead to steroid-dependency. Suboccipital steroid injection may be an effective 'single shot' alternative, but no placebo-controlled trial is available. The aim of our study was to assess in a double-blind placebo-controlled trial the preventative effect on CH attacks of an ipsilateral steroid injection in the region of the greater occipital nerve. Sixteen episodic (ECH) and seven chronic (CCH) CH outpatients were included. ECH patients were in a new bout since no more than 1 week. After a one-week run-in period, patients were allocated by randomization to the placebo or verum arms and received on the side of attacks a suboccipital injection of a mixture of long- and rapid-acting betamethasone (n=13; Verum-group) or physiological saline (n=10; Plac-group). Acute treatment was allowed at any time, additional preventative therapy if attacks persisted after 1 week. Three investigators performed the injections, while four others, blinded to group allocation, followed the patients. Follow-up visits were after 1 and 4 weeks, whereafter patients were followed routinely. Eleven Verum-group patients (3 CCH) (85%) became attack-free in the first week after the injection compared to none in the Plac-group (P=0.0001). Among them eight remained attack-free for 4 weeks (P=0.0026). Remission lasted between 4 and 26 months in five patients. A single suboccipital steroid injection completely suppresses attacks in more than 80% of CH patients. This effect is maintained for at least 4 weeks in the majority of them.

17 November 2004 in Brain
Verified
Journal Article
Open access
PDF file
Gianluca CoppolaGianluca Coppola
Gianluca Coppola
MVMichel Vandenheede
Michel Vandenheede
LCLaura Di Clemente
Laura Di Clemente
AAAnna Ambrosini
Anna Ambrosini
AFArnaud Fumal
Arnaud Fumal
JSJean Schoenen
Jean Schoenen
A deficit of habituation in cortical information processing, including somatosensory evoked potentials (SSEPs), is the most consistent neurophysiological abnormality in migraine patients between attacks. To explore further the mechanisms underlying this interictal neural dysfunction, we have studied the high-frequency oscillations (HFOs) embedded in SSEPs because they are thought to reflect spike activity in thalamo-cortical cholinergic fibres (early HFOs) and in cortical inhibitory GABAergic interneurons (late HFOs). Untreated migraine patients with (MA) and without (MO) aura were recorded during (n = 13: nine MO, four MA) and between attacks (n = 29: 14 MO, 15 MA) and compared with healthy volunteers. SSEPs were filtered off-line (digital band-pass between 450 and 750 Hz) to extract the two HFO bursts from the broad-band contralateral N20 somatosensory cortical response obtained by median nerve stimulation. In both migraine groups, amplitudes and latencies of conventional broad-band SSEPs recorded interictally from cervical and parietal active electrodes were not significantly different from those found in healthy volunteers. In contrast, maximum peak-to-peak amplitude and area under the rectified curve of the early HFO burst were significantly smaller in both MA and MO patients than in healthy volunteers. There was no significant difference in the later HFO burst between migraineurs and healthy volunteers. During attacks, all electrophysiological measurements in migraineurs were similar to those found in healthy volunteers. Thalamo-cortical activation, as reflected by the early SSEP HFO burst, may thus be reduced in migraine interictally, but normalizes during an attack, whereas intracortical inhibition, as indexed by the late HFO burst, is normal at any time. This supports the hypothesis that the habituation deficit in migraineurs is due to a reduced pre-activation level of sensory cortices and not to increased cortical excitability or reduced intracortical inhibition.

1 June 2003 in Clinical Neurophysiology
Verified
Journal Article
Closed access
JSJean Schoenen
Jean Schoenen
AAAnna Ambrosini
Anna Ambrosini
PSPeter S Sándor
Peter S Sándor
ANAlain Maertens de Noordhout
Alain Maertens de Noordhout

1 December 2007 in Cephalalgia
Verified
Journal Article
Closed access
Gianluca CoppolaGianluca Coppola
Gianluca Coppola
AAA Ambrosini
A Ambrosini
LCL Di Clemente
L Di Clemente
DMD Magis
D Magis
AFA Fumal
A Fumal
JSJ Schoenen
J Schoenen

1 May 2003 in Cephalalgia
Verified
Journal Article
Closed access
AAA Ambrosini
A Ambrosini
ANAm de Noordhout
Am de Noordhout
PSPs Sándor
Ps Sándor
JSJ Schoenen
J Schoenen